Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News OS Therapies’ OST-HER2 achieves milestone in osteosarcoma treatment OS Therapies, Inc., a clinical-stage biotechnology company, has announced data from its Phase 2b trial of OST-HER2, an… byPallavi MadhirajuJanuary 15, 2025